Arch Therapeutics, Inc.
company.status.inactiveCIK 1537561fmd_07FHQ5SM5319AM3GVYE416HDH0Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Oct 01, 2006 to Jun 30, 2024, 58 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Gross profit | – | – | – | – | – | – | – | (0) | (0) | (0) |
| Research and development | 1 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 |
| Selling, general and administrative | – | – | – | – | – | – | 4 | 5 | 5 | 4 |
| Total operating expenses | 5 | 5 | 6 | 7 | 7 | 6 | 5 | – | – | – |
| Operating income | (5) | (5) | (6) | (7) | (7) | (6) | (5) | (6) | (6) | (5) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 1 | 3 |
| Other non-operating income (expense) | – | – | – | – | – | – | – | 0 | 0 | (2) |
| Income tax expense | – | – | – | – | – | – | – | – | – | – |
| Net income | (8) | (3) | (6) | (8) | (5) | (5) | (5) | (6) | (5) | (7) |